Among the large drugmakers, Eli Lilly, AstraZeneca, Pfizer, Sanofi and Bayer are worth retaining in one’s portfolio.

With its recent US Food and Drug Administration (FDA) approval, Eli Lilly’s Ebglyss (lebrikizumab) adds a new competitor to ...

Less frequent dosing could provide Eli Lilly’s Ebglyss room to rival Sanofi and Regeneron’s blockbuster Dupixent.

Nurix Therapeutics offers promising targeted protein degradation treatments for cancer and autoimmune diseases. Find out what ...

Drugs Market Growth is Driven by Rising Consumer Awareness, Growth of Lifestyle Diseases, and Expanding Distribution Channels Drive Market Growth; U.S. and Asia-Pacific Regions See Notable ...

Discover the major biotech partnerships, collaborations and mergers and acquisitions that made headlines in September 2024.

The Company is primarily engaged in the business of manufacturing and trading of drugs s and pharmaceuticals. It has its own manufacturing facility at Goa. It sells products through independent ...

Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncologic, ...

The Indian pharmaceutical sector faces mixed growth with a 12% YoY and 5% QoQ rise while IPM growth is projected at 8%.

Patient advocacy group uses report data to push solutions on air pollution, access to medicine, health equity 2024 Asthma ...

The Indian pharmaceutical sector is anticipating a mixed quarter with overall slow growth, but key players like Dr. Reddy's ...

Recombinant Dna Technology Market Set To Witness Significant Growth By 2024-2031: Sanofi , Pfizer, Inc., Amgen, Inc. Recombinant Dna technology market is expected to reach USD 327.63 Bn by 2031, ...